Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
107 items
Colorful artistic visualization of the retina.

Measuring Levels of Proteins in Eye Fluid May Accurately Predict Need for Lifelong Macular Degeneration Therapy

June 29, 2022

Johns Hopkins Medicine researchers say they have found that levels of a specific protein appears to help accurately predict whether people with the wet form of age-related macular degeneration may need lifelong, frequent eye injections to preserve vision.

NIH study confirms benefit of supplements for slowing age-related macular degeneration

June 2, 2022

The AREDS2 formula not only reduces risk of lung cancer due to beta-carotene, but is also more effective at reducing risk of AMD progression, compared to the original formula.

Life after death for the human eye

May 11, 2022

Scientists have revived light-sensing neuron cells in organ donor eyes and restored communication between them as part of a series of discoveries that stand to transform brain and vision research.
none

Retinal cell map could advance precise therapies for blinding diseases

May 6, 2022

Researchers have identified distinct differences among the cells comprising a tissue in the retina that is vital to human visual perception. The scientists from the National Eye Institute (NEI) discovered five subpopulations of retinal pigment epithelium.
Photoreceptor degeneration tied to lipofuscin accumulation.

Advancing a treatment for a common eye disease that lacks one

April 1, 2022

The road from discovering a potential drug to getting the therapy into the hands of patients is a long and uncertain one. An NIH program called Blueprint Neurotherapeutics Network helps basic researchers prep for clinical trials and regulatory approval.
Green retinal ganglion cell spreads dendrites in all directions.

Antabuse may help revive vision in people with progressive blinding disorders

March 18, 2022

Researchers at the University of California, Berkeley, have found that a drug once widely used to wean alcoholics off of drinking helps to improve sight in mice with retinal degeneration.
Artist's rendering of photoreceptor signaling a retinal ganglion cell

Implanted chip, natural eyesight coordinate vision in study of macular degeneration patients

February 4, 2022

A Stanford scientist and his colleagues show that patients fitted with a chip in their eye are able to integrate what the chip “sees” with objects their natural peripheral vision detects.
Schematic summarizing the research by Sodhi’s team.

Study Finds Up to 30% of Patients with Wet Macular Degeneration Can Safely Stop Eye Injections

January 18, 2022

In a preliminary study, Johns Hopkins Medicine researchers report that as many as a third of those with "wet" age-related macular degeneration may someday be able to safely stop eye injection therapy without further vision loss.
Man with patch over his eye.

Cataract surgery does not cause disease progression in people with AMD

December 15, 2021

People with age-related macular degeneration (AMD) can undergo cataract surgery without fear of worsening their disease.
none

NIH researchers identify potential AMD drugs with stem-cell based research tool

December 15, 2021

Using a stem-cell-derived model, researchers have identified two drug candidates that may slow dry age-related macular degeneration (AMD), a leading cause of blindness for which no treatment exists.